Logistic regression models are commonly used to study the association between a binary response variable and an exposure variable. Besides the exposure of interest, other covariates are frequently included in the fitted model in order to control for their effects on outcome. Unfortunately, misspecification of the main exposure variable and the other covariates is not uncommon, and this can adversely affect tests of the association between the exposure and response. We allow the term "misspecification" to cover a broad range of modeling errors including measurement errors, discretizing continuous explanatory variables, and completely excluding covariates from the model. This paper reviews some recent results on the consequences of model misspecification on the large sample properties of likelihood score tests of association between exposure and response.
Introduction
Data analysts are often interested in assessing the association between a response variable and an explanatory variable. In addition to collecting data on the response variable and explanatory variable of interest, they may also collect data on other covariates in order to control for the covariates' effects. Unfortunately, misspecification of the main explanatory variable and the other covariates is not uncommon, and this can affect tests of the association between the explanatory variable and the response. This paper reviews some recent results on the consequences of model misspecification on the validity and power of tests of association between an explanatory variable and a binary response variable.
Suppose that x denotes the explanatory variable of interest, and z denotes a vector of other explanatory variables. For simplicity of presentation, we shall hereafter refer to x and z as the exposure variable and covariates, respectively. When the outcome of interest is binary, logistic regression models are commonly used to study the association between exposure and response. If Y denotes the binary response, then the relationship between exposure and response is modeled as: logit Pr(Y = lIx,z) = 0 + ax + ,'z (1) where 0, a, and , are unknown parameters. The null hypothesis of no association between exposure and outcome can be expressed as:
Ho:a = 0
Given n independent and identically distributed observations of the form (Yi, xi, zi), i = 1,2, .. ,n, this hypothesis can be assessed using the likelihood score test of a -0, say Q (x,z), which is asymptotically equivalent to tests of a = 0 based on the maximum likelihood estimator of a and on the likelihood ratio statistic (1) .
Suppose that x denotes a misspecified version of xi, and z4 denotes a misspecified version of zi. We consider the test statistic, say Q(x*,z*), having the same functional form as Q(x,z), but with xi and zi replaced by X and 4i, respectively. We want to know the properties of this new statistic for different types of misspecification. We allow the term "misspecification" to cover a broad range ofmodeling errors for x and z. It can include measurement error, mismodeling the functional form of x or z (e.g., using x* = weight instead of x = weight2), discretizing a continuous x or z, or completely excluding covariates from the model. This misspecification can be arbitrary, but we require throughout this discussion that the distribution of Y conditional on x, x*, z, and z* be equal to the distribution of Y conditional on x and z alone. In words, this means that once we have x and z, x* and z* provide no additional information about Y. This paper investigates the consequences of using Q (x*,z*) rather than Q(x,z) as a test of a = 0. The issue of estimation, albeit interesting, will only be discussed briefly for the problem of omitted covariates.
There are various ways of assessing the ramifications of using Q(x*,z*) instead of Q(x,z). We will focus on the asymptotic distributions of Q(x,z) and Q(x*,z*) because their exact distributions are, in general, intractable. where 0 and ,B are the restricted maximum likelihood estimators (MLEs) of parameters 0 and ,B when a = 0, and w arises from the sample information matrix (1) . Although the exact distribution of Q(x,z) is quite complex, it can be shown to be asymptotically N(O, 1) when a = 0. This is used in practice to compute significance levels.
To obtain an approximation to the distribution of Q(x,z) when a = 0, one can use its asymptotic distribution for a sequence of contiguous alternative models to Eq. (1). This leads to the result (1,2) that
where ,u depends on 0, a, ,B and the joint distribution of x and z. The magnitude of ,u reflects the asymptotic power of Q(x,z); the larger RI is, the larger the asymptotic power. Now consider the asymptotic distribution of Q(x*,z*). To derive this limiting distribution, we again specify a particular sequence of contiguous alternative models in which the fitted model approaches the true model Eq.
(1) as n goes to infinity. In this way, it can be shown (2) that Q(x*,z*) is also asymptotically normal:
where ,u* depends on 0, a0, IS, the joint distribution of X, x*,z, and z*. Thus, Q(x*,z*) is asymptotically valid if , = 0 when a = 0. The asymptotic relative efficiency (ARE) of Q(x*,z*) to Q(x,z), when the former is valid, is given by (V*/VL)2. The ARE can be interpreted loosely as the ratio of sample sizes needed to achieve the same power. For example, if the ARE is 0.9, then the correct test attains the same power as the mismodeled test with about 90% as many observations. In the following sections, we will evaluate this result when the model has no covariates, when the model contains correctly specified covariates, and when the model contains misspecified forms for both exposure and covariates. In each setting, we consider conditions for Q(x*,z*) to be valid and then examine its efficiency relative to the correct test.
Misspecified Exposure in the Absence of Covariates
The special case in which there is a misspecified exposure in the absence of other covariates has received considerable attention, and the reader is directed to the papers of Lagakos (3) and Tosteson 
Thus, the consequences of misspecifying exposure are reflected by the squared correlation between the fitted and correct measures of exposure. Recall that the ARE can be thought of as the ratio of sample sizes required by two tests in order to achieve the same power. This result says that correlation squared provides a way to make this comparison. Scale and location changes to x or x* will not alter the ARE, since correlation enjoys the property of location/scale invariance. Furthermore, because correlation is a symmetric quantity, the ARE of Q(x*) to Q(x) when x is the appropriate exposure variable is equal to the ARE of Q(x) to Q(x*) when x* is the appropriate exposure variable. The equality of the ARE for model misspecification to the square of the correlation arises not only in logistic models, but in a broad range of other settings. These include MLE tests based on linear models for measured response, MLE tests from logistic models for binary response, and likelihood ratio tests from logistic models for dichotomous response (3, 4) .
In order to get a sense for the effects of mismodeling, let us consider the consequences of a particular kind of misspecification, discretizing a continuous exposure variable. Other If we want to group a continuous exposure into several categories, a few choices must be made. First we must decide on k, the number of categories. Once k is selected, we must choose the (k-1) cutpoints that form the boundaries for k intervals. Finally we must decide upon the value, say xj*, of x* when x falls into interval j. For a given k and cutpoints, it is easily shown (5) that the optimal choice for Xj* is xj* = Oj, where Oj is the mean of x within interval j. The corresponding ARE, obtained by simplifying Eq. (3), is given by:
where arj is the probability that x falls into the jth interval, and 0 = E(x). Connor (5) derives this same result as an optimization criterion for categorizing a continuous exposure that is linearly related to a dichotomous outcome variable. He provides an iterative algorithm for finding the optimal cutpoints for k intervals. In general, the optimal intervals are not equiprobable.
To illustrate the numerical results that arise from Eq. (4), let us consider instances in which x is distributed uniformly, normally, and exponentially. Results Lessening wr causes the ARE to decrease slightly, but this loss is small. Increasing C, on the other hand, can lead to a great loss in power; the score test becomes highly inefficient when the coefficient of variation is large.
Misspecified Exposure and Correctly Specified Covariates
Now let us consider a more complex situation; suppose that x is misspecified in the presence of correctly specified covariates. The goal, then, is to study the behavior of Q(x*,z), the misspecified version of the score test. The asymptotic distribution of Q(x*,z) can be derived for a sequence of contiguous alternative models to Eq. (1); such a sequence is described by Eq. (1) However, computation of the efficiency of Q(x*, z) relative to Q(x,z) can be quite complex for the general case (2) . But if we restrict attention to the special case in which scalar z is independent of x and x*, we obtain a much simpler result. Therefore, suppose that the covariate z is independent of both x and x*; that is, that the covariate is balanced across exposures, as in a ran- 
Misspecified Exposure and Covariates
Let us now consider the situation in which both exposure and covariates are misspecified. Denote the test statistic in this case by Q(x*,z*). Again, one can derive the asymptotic distribution of the mismodeled test statistic by specifying a sequence of contiguous alternative models to Eq. (1) such that the fitted model approaches the true model under the null hypothesis as n goes to infinity. The limiting distribution of Q(x*,z*) has already been derived under very general conditions. This general approach specifies a sequence of alternative models to Eq. (1) in which a is replaced by ao/V71 and z* approaches z at rate 0 (1/\in) as n goes to infinity.
This latter assumption has no direct physical significance; it is merely a technique which guarantees a tractable result. It follows that this statistic also converges in distribution to a normally distributed random variable with mean ,u* and variance 1. The formula for ,u* is very complex and involves intricate expressions that depend on 0, xo, rB, and on the joint distribution of x, x*, z, and z* (2) .
In general, Q(x*,z*) is not asymptotically valid. Clearly this result is reasonable, since we would expect mismodeling a covariate z that is not balanced across exposure groups to introduce bias. When Q(x*,z*) is valid we can consider its asymptotic efficiency relative to Q(x,z*). As we would expect, misspecification of covariates causes a loss in asymptotic efficiency. However, formulas for the ARE[(x*,z*):(x,z*)] do not readily simplify. In general, numerical techniques are needed to evaluate these expressions and quantify the extent of power loss.
Results do simplify, to some extent, for the case of omitted covariates (6) . Since it is well known that excluding covariates that are related to exposure alters test size and efficiency, we restrict attention to the case where the omitted covariates are independent of exposure. It has been shown (6) that omitting an important covariate will not distort test size; hence, the test statistic Q(x*,0) retains asymptotic validity. Covariate omission does, however, reduce efficiency. We have the following expression for the ARE of a misspecified test which excludes z versus a misspecified test-which includes z: Begg and Lagakos (6) .
This result addresses the issue of covariate omission in a general way. Earlier results, however, have dealt with the consequences of omitting important covariates in particular applications. We present two such special cases as examples. The first result examines the consequences of omitting a covariate on estimating treatment effect. The second result, taken from the field of animal carcinogenicity experiments, studies the loss in efficiency incurred by omitting an important covariate from the model. For other examples, see the references in the papers by Gail et al. (7) and Ryan (8) .
Estimation of Treatment Effect. Suppose that an important scalar covariate has been excluded from the fitted model, but that this covariate is balanced across exposure groups; that is, x and x* are independent of z and z*. Such is the situation in a randomized clinical trial where covariates are balanced across treatment groups. It is well known that the omission of a balanced covariate will not bias the estimate of treatment effect in the setting of linear models. However, Gail et al. (7) have shown that this is not necessarily the case with nonlinear regression. The authors show that when treatment x is binary, the omission of a balanced covariate z in logistic regression causes the estimate of treatment effect to be biased towards the null hypothesis. This result emphasizes the fact that for logistic models, randomization cannot guarantee unbiased estimates of treatment effect when important covariates are omitted.
Animal Carcinogenicity Experiments. As an example, let us consider a bioassay experiment in which a control group of animals is compared with an exposed group with respect to the development of a nonlethal tumor. One approach for analysis is the lifetime incidence test, which compares the proportions of tumorbearing animals. This test is valid, provided that the compound in question does not alter longevity in the exposed group. However, Ryan (8) The case with a single exposure variable has already been researched extensively. When there are no covariates, the misspecified score test is always valid. Its efficiency was evaluated by computing the ARE of a test based on the misspecified exposure variable versus a test based on the correctly specified exposure variable. The simple result is that the ARE[x*:x] is equal to the square of the correlation between the fitted exposure variable and the correct exposure variable.
When there are other covariates besides the exposure, the score test retains its validity. However, when an independent scalar covariate is present, the ARE differs slightly from the ARE in the absence of covariates. The formula for ARE[(x*,z):(x,z)] is approximately equal to the square of the correlation between xz and x*z. This formula resembles the formula for the ARE when there are no covariates, but takes into account the presence of z.
Finally, we considered cases in which there has been misspecification of both exposure and covariates. As we would expect, this case gives the most complex results. We find that bias is indeed of concern here. The score test is no longer valid in general. We also find that expressions for the ARE[(x*,z*):(x,z*)] become extremely complicated in this setting. Evaluation of the ARE will usually require numerical techniques for the general case. Of particular interest in this setting is the question of the omitted covariate. It can be shown that the omission of a needed covariate causes biased estimates of treatment effect, and reduced efficiency in tests of association between exposure and response.
The methods given here for evaluating bias and efficiency prove to be quite flexible. They allow for misspecification of the exposure, the covariates, or both simultaneously. These results derive from the likelihood score test from a logistic model, but also apply to tests based on the maximum likelihood estimator of a and the likelihood ratio statistic, since all three tests are asymptotically equivalent. It has been beyond the scope of this paper to consider all possible types of misspecification of the exposure, all types of misspecification of the covariates, and all combinations thereof. Our purpose has been to provide the machinery for doing so and to give a few illustrative examples. The generality of the results allows us to think more generally about the effects of misspecification, but their ultimate value depends on detailed numerical evaluations to develop simple rules of thumb.
